Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SMN2 stimulants(Survival motor neuron protein stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Spinal Muscular Atrophy | Preclinical | US | 19 Oct 2016 |